Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma

August 12, 2026 | Comments Off on Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma

Scientific Reports 2026 June 1 [Link] Xiaofeng Liao, Chen Li, Ming Huang, Zheng Yao, Shikun Luo, Xiaoyu Lei Abstract Malignant peritoneal mesothelioma (MPM) is a rare, aggressive cancer with limited…

Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation

August 11, 2026 | Comments Off on Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation

Radiology Case Reports 2026 May 19 [Link] Kaspar L Yaxley, Tristan Rutland, Thisuri Jayawardena, David Law, Yuranga Weerakkody Abstract Malignant mesothelioma is an aggressive neoplasm arising from mesothelial cells, typically…

Feasibility and Outcomes of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion for Pleural Mesothelioma

August 10, 2026 | Comments Off on Feasibility and Outcomes of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion for Pleural Mesothelioma

The Annals of Thoracic Surgery 2026 May 28 [Link] Yota Suzuki, Inderpal S Sarkaria, Edra Ha, Ian G Christie, Olugbenga T Okusanya, Omar Awais, Evan T Alicuben, Ryan M Levy,…

A High-Fidelity Patient-Derived Organoid Platform Recapitulates the Dynamic Metabolic Landscape of Cisplatin Tolerance in Mesothelioma

August 7, 2026 | Comments Off on A High-Fidelity Patient-Derived Organoid Platform Recapitulates the Dynamic Metabolic Landscape of Cisplatin Tolerance in Mesothelioma

Cancers 2026 May 7 [Link] Zivile Useckaite, Ashleigh J Hocking, Lauren A Mortimer, John Salamon, Simon Lee, Yazad Irani, Lucy Franzon, Arya L Arul, Sarita Prabhakaran, Sonja Klebe Abstract Background:…

Quercetin-Arctigenin Co-Treatment Induces Mitochondrial Dysfunction and Apoptotic Cell Death Through Metabolic Stress in Malignant Mesothelioma Cells

August 6, 2026 | Comments Off on Quercetin-Arctigenin Co-Treatment Induces Mitochondrial Dysfunction and Apoptotic Cell Death Through Metabolic Stress in Malignant Mesothelioma Cells

Life 2026 May 6 [Link] Moon-Kyun Cho, Sang-Han Lee, Hae-Seon Nam, Yoon-Jin Lee Abstract Malignant mesothelioma is an aggressive cancer with limited therapeutic options, highlighting the need for novel strategies…

Increased Toll-like receptor 9 expression associated with cellular proliferation and poor prognosis in pleural mesothelioma

August 5, 2026 | Comments Off on Increased Toll-like receptor 9 expression associated with cellular proliferation and poor prognosis in pleural mesothelioma

Journal of Pathology and Translational Medicine 2026 July [Link] Ali Omar Abdelaziz, Dina Moustafa Thabit, Rehab Mohamed Kamal, Hend Moness, Rasha Fouad Ahmed, Mariana Fathy Gayyed, Fatma El Zahraa Ammar…

The role of microRNAs and competing endogenous RNA regulatory networks in mesothelioma response to immunotherapy

August 4, 2026 | Comments Off on The role of microRNAs and competing endogenous RNA regulatory networks in mesothelioma response to immunotherapy

Lung Cancer 2026 July [Link] Farhad Kosari, Paul Baas, Maria Disselhorst, Kim Lauer, Tobias Peikert, Stephen Murphy, Janet Schaefer Klein, Aaron S Mansfield Abstract Assessing the contributions of microRNAs to…

FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic target

August 3, 2026 | Comments Off on FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic target

Journal of Translational Medicine 2026 May 21 [Link] Valentina Doldi, Chiara Maura Ciniselli, Claudia Aurelio, Enrica Favini, Silvio Marco Veronese, Fabio Bozzi, Shigeki Kusamura, Dario Baratti, Silvia Martini, Paolo Verderio,…

Metabolic vulnerabilities in pleural mesothelioma

July 31, 2026 | Comments Off on Metabolic vulnerabilities in pleural mesothelioma

Oncogenesis 2026 May 20 [Link] Sílvia Plans-Marin, Cristina Muñoz-Pinedo, Ernest Nadal Abstract Mesothelioma is a rare tumour of mesothelial origin that is often diagnosed at advanced stages. Despite recent approval…

The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

July 30, 2026 | Comments Off on The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

Diagnostic Cytopathology 2026 May 20 [Link] Suzanne M Selvaggi Abstract Background: Mesothelioma is a rare tumor that arises from the serosal cells lining the serous cavities, most commonly the pleura…

Categories